Overview
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Lobbying Costs
None declared
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
0.5 Fte (1)
Lobbyists with EP accreditation
0
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
European Alliance for Access to Safe Medicines (EAASM)
EU Transparency Register
861368611058-84 First registered on 29 Apr 2013
Goals / Remit
The EAASM will strive to ensure that most patients within the EU are aware of falsified and substandard medicines and unsafe medical practices and that national governments have put in place mechanisms to protect the population.
The EAASM through innovative projects and activities will produce tangible and measurable outputs that have a significant bearing on making medicines and medical practices safer for the European population.Main EU files targeted
The EAASM is following closely the implementation of the Falsified Medicines Directive. The EAASM is also involved in activities relating to patient safety in the areas of off label use of medicines, compounding of medicines, regulatory aspects concerning nanomedicines. It has also involved in a major medication error and traceability patient safety project with the aim to significantly reduce medication errors by enhancing traceability processes within the hospital environment.
Address
Head Office
12 Camden Road Dublin 8
Dublin D08 R9CN
IRELANDEU Office
20 MADEIRA PARK Madeira Park
TUNBRIDGE WELLS TN2 5SX
UNITED KINGDOMWebsite
-
People
Total lobbyists declared
1
Employment time Lobbyists 50% 1 Lobbyists (Full time equivalent)
0.5
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 12 Sep 2024
Name Start date End Date Mr Michael Isles 15 Jun 2022 15 Jun 2023 Mr Michael Isles 08 Mar 2019 07 Mar 2020 Mr Michael Isles 20 Nov 2017 15 Nov 2018 Mr Michael Isles 11 Feb 2016 10 Feb 2017 Mr Michael Isles 01 Oct 2014 29 Sep 2015 Complementary Information
The Executive Director spends up to 2 days per week working on EAASM activities. He is paid for this work.
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Non-governmental organisations, platforms and networks and similar
-
Networking
Affiliation
The EAASM is an active member of the Alliance for Safe Online Pharmacy in the EU (ASOP EU) Community Interest Company (www.asop.eu). As such, it contributes to the development of this not for profit collaborative group. (Participants in ASOP EU are united by a single mission that together they can create an environment that enables patients to buy their medicines online safely, in countries where it is legal for them to do so). The EAASM is also a civil Society member of the EUIPO/Observatory and is an expert with the Expert group of "Search engines". The EAASM is also a National Association of Boards of Pharmacy - DotPharmacy Executive Board Member. It is an active member of the EU Health Coalition as well as having multiple connections to patient safety organisations due it being the secretariat of the ECAMET Alliance and the Nanomedicines Regulatory Coalition.
Member organisations
None declared
-
Financial Data
Interests represented
Does not represent commercial interests
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
Since 20 September 2021 self-declared 'non-commercial organisations' are no longer required to provide a lobby budget. See above timeline for this registrant's historical lobby budget.
Total organisational budget in closed year
20,663€
Major funding types in closed year
Other, Member's contribution
Funding types "other" information
Major contributions in closed year
None declared
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
Artificial intelligence and digital#Cancer
Participated in ESNO and PACT meetings and Health First Europe meetings. Also Civil Society member of The Observatory (EUIPO).Communication activities
The EAASM is actively involved with the EU Parliament and attends relevant meetings and hosts Healthcare debates in the Parliament bringing together MEPs, Commission and the Council.
The EAASM has been active and successful in calling for amendments to the draft European Parliament Own-initiative Report: "Safer healthcare in Europe: improving patient safety and fighting antimicrobial resistance". The EAASM recalls that the EU pharmaceutical legislation was put in place to protect patient safety.
The EAASM was active in contributing to DG SANTE scoping study on off label usage of medicines. The EAASM strongly believes that the Member States' medical professionals inform patients when a medicine is used off-label; and to provide patients with information on the potential risks in order to enable them to give fully informed consent. The EAASM supports the GOLUP approach relating to the process by which off label usage of medicines is decided.
The EAASM recalls that the Internet is the largest unregulated pharmaceutical market place in the world with 62% of medicines purchased online being falsified or substandard with 95.6% of online pharmacies researched operating illegally. The EAASM calls on the European Commission and the Member States to build on the introduction of the Common Logo for online pharmacies (Implementing Regulation No 699/2014) and to extend it to a Europe-wide protocol for licensing online pharmacies which could potentially align with the pre-qualifications of the .pharmacy domain suffix which is well governed by the National Association of Boards of Pharmacy.
The EAASM also supports the objectives and recommendations for the Pharmaceutical Strategy for Europe with the EU Healthcare Coalition which it is a partner. It has also contributed to the EU Commission Structural Dialogue initiative on product shortages.
It has published a number of reports and communications which can be found on the ECAMET Alliance website (https://ecamet.eu) and the Nanomedicines Regulatory Coalition website (https://eunanomedicinescoalition.eu)Other activities
None declared
Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 30 May 2022 Location Webex Subject Nano-medicines and EU regulatory Framework. Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)